MYHEMVIE

LIVE

Serial Number

79309123

Owner

Bluebird Bio (UK) Ltd.

Attorney

Christopher K. Albert

Filing Date

Feb 26, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MYHEMVIE Trademark

Serial Number: 79309123 • Registration: 6784061

MYHEMVIE is a trademark filed by Bluebird Bio (UK) Ltd. on February 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Legal Representation

Attorney of Record

Christopher K. Albert

158 trademarks filed View all →

Correspondence Address

Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.

155 Seaport Blvd.

Boston, MA 02210

United States

Trademark Details

Filing Date

February 26, 2021

Registration Date

July 12, 2022

Published for Opposition

April 26, 2022

Goods & Services

Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 18, 2025 ADCH

NEW REPRESENTATIVE AT IB RECEIVED

Nov 14, 2025 NREP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 18, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 18, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 18, 2025 REAP

NEW REPRESENTATIVE AT IB RECEIVED

Sep 13, 2024 NREP

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 23, 2023 ADCH

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 14, 2022 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Oct 19, 2022 FICS

FINAL DISPOSITION PROCESSED

Oct 19, 2022 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 12, 2022 FICR

CHANGE OF NAME/ADDRESS REC'D FROM IB

Aug 26, 2022 ADCH

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 12, 2022 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 12, 2022 R.PR

NOTIFICATION PROCESSED BY IB

May 9, 2022 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 26, 2022 NPUB

PUBLISHED FOR OPPOSITION

Apr 26, 2022 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 13, 2022 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 13, 2022 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 6, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 22, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 11, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 10, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 10, 2022 TROA

REFUSAL PROCESSED BY IB

Oct 25, 2021 RFNT

NEW REPRESENTATIVE AT IB RECEIVED

Oct 9, 2021 NREP

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 15, 2021 RFCS

REFUSAL PROCESSED BY MPU

Sep 15, 2021 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 12, 2021 RFCR

NON-FINAL ACTION WRITTEN

Sep 11, 2021 CNRT

ASSIGNED TO EXAMINER

Sep 9, 2021 DOCK

CHANGE OF OWNER RECEIVED FROM IB

Aug 13, 2021 CHLD

APPLICATION FILING RECEIPT MAILED

Apr 27, 2021 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 23, 2021 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 22, 2021 REPR

Related Trademarks

More from this Owner

G GENETIX BIOTHERAPEUTICS

GENETIX BIOTHERAPEUTICS

G GENETIX BIOTHERAPEUTICS

ZYNTEGLO

More in Same Class

MAGAPOR